20.02.12 RNA based techniques Flashcards

1
Q

Disadvantages of using RNA for molecular testing

A
  • Short half life
  • Specialist extraction kits and reagents required
  • Ultra-clean labs needed
  • Limited expression patterns means that the diseased tissue is required, not always available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

RNA mutation detection techniques

A
  • Reverse transcription PCR
  • Minigenes
  • Northern blotting
  • RNA sequencing
  • Microarray
  • RNAse protection assay
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What can reverse transcriptase PCR be used for

A
  • Qualitatively detect gene expression
  • Quantification of RNA
  • Monitoring of residual disease
  • Confirm/exclude pathogenicity of variants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens in RT PCR

A
  • RNA species is reverse transcribed into a single stranded cDNA/ RNA hybrid.
  • THe RNA is then digested and DNA polymerase generates a second DNA strand.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

To create cDNA what primers can be used

A
  • Oligo-dT. Anneal to polyA tail of mRNA. cDNA population with 3’ bias. Means PCR primers that target 5’ end of transcripts may be less effective.
  • Random hexamer primers. Have a random mix of the 4 bases, so bind anywhere with complimentary sequence.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Do RNA secondary structure/ lack of poly A tails affect cDNA yeild

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Benefits to using of RT-PCR for mutation detection

A
  • Large genes can be analysed in fewer fragments than gDNA

- Detects splicing aberrations and deep intronic variants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Problems to using of RT-PCR for mutation detection

A
  • Need appropriate tissue to obtain relevant RNA isoform.

- Mutations that result in premature stop codons could lead to mRNA degradation due to NMD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CMGS BP guidelines on unclassified variants recommending using what to ensure that mRNA from both loci are represented in cDNA

A

SNPs or polymorphic loci.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Considerations to make when using RT-PCR to look at VUS with possible splicing effects

A
  • Need to obtain mRNA from correct tissue/ cell type
  • Need to compare to a normal control (need understanding of naturally occurring splice variants and relative proportions)
  • Need to rule out possibility of NMD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What gene fusion occurs in chronic myeloid leukaemia (CML)

A
  • BCR-ABL
  • Exon 13 or 14 of BCR fuses to ABL exon 2.
  • Makes a 210kDa fusion protein (p210)= an abnormal tyrosine kinase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drug can be used to block activity of BCR-ABL fusion product p210?

A

Imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Use of RT-PCR for BCR-ABL detection

A
  • Transcript monitoring during treatment

- prognostic indicators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Benefits of RT-PCR

A
  • Requires small amounts of starting material

- Several methods available to suit needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cons of RT_PCR

A
  • Difficult to maintain linerarity
  • Sensitive to DNA contamination
  • Variation in template concentration and amplification efficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are minigene assays

A

Vector based ex vivo method used to study the effects of variants of unknown clinical significance on splicing

17
Q

What can minigene assays be used for

A

-To elucidate cis- / trans- regulatory elements and other regulators of pre-mature RNA splicing in vivo

18
Q

Steps in minigene assay

A
  • A specific region of a gene is amplified using the patient’s DNA and a normal control i
  • ligated into a plasmid expression vector, most commonly pcDNA3.1A or USR13.
  • transfectedinto E.coli
  • colonies (clones) containing the recombinant plasmid are identified by PCR.
  • Clones are then sequenced to identify those clones which have the normal sequence and those with the variant sequence.
  • DNA from each and a control empty vector are transfected into cultured human cells which are allowed to express the mingene for 24hr.
  • RNA is then prepared from the cells and analysed by RT-PCR and sequencing to determine if there is a difference between the RNA (cDNA) synthesised from the normal minigene and that synthesised from the minigene with the variant sequence.
19
Q

Disadvantages of minigene assays

A
  • May not replicate in vivo splicing patterns.
  • labour intensive compared to RT_PCR
  • Requires specialist facilities and equipment
20
Q

What is northern blotting

A
  • electrophoretic separation of RNA samples by size,
  • Transfer of RNA from gel to membrane
  • detection with a hybridization probe complementary to part of or the entire target sequence.
21
Q

What can northern blotting be used for

A
  • To study gene expression (compare band intensities for different tissues)
  • To detect splicing isoforms, compare tissue specific variations in splice isoforms.
22
Q

Advantages of N. blotting

A
  • Able to detect small changes in gene expression
  • Can detect RNA size
  • Can determine alternate splicing products
  • Probes only need partial homology
23
Q

disadvantages of N. blotting

A
  • Sample degradation by RNAses
  • CHemicals (e.g. radioactive labels) are harmful to users
  • Only looking at one or a small number of genes
  • No amplification so transcripts expressed at low levels are less suitable
24
Q

RNA expression arrays do what

A

Measure RNA to find gene expression changes

25
Q

Common used for RNA expression arrays

A

Tumour profiling

26
Q

Advantages of RNA expression arrays

A

-Measures mRNA transcripts of thousands of genes simulatenously.

27
Q

Disadvantages of RNA expression arrays

A

Only known genes or ESTs (expressed sequence tags) can be analysed

28
Q

WHater are miRNAs

A
  • MicroRNAs

- Differentially expressed in tissues

29
Q

What do miRNAs do

A
  • Involved in the development of organisms
  • Negative regulators of mRNA translation
  • Involved in viral infection processes.
  • Associated with oncogenes.
30
Q

Uses of miRNA expression profiling

A
  • Insight into gene regulation mechanisms
  • Biological subgrouping, i.e. cancer biomarkers
  • Identification of potential therapeutic miRNA targets
31
Q

What is RNA seq

A

NGS sequencing of the trasncriptome

32
Q

Uses of RNA seq

A
  • Quantitative assessment of RNA

- Identification of novel transcripts including non-coding RNA, miRNA, siRNA and other small RNAs

33
Q

Advantages of RNA-seq over microarray technology

A
  • RNA seq does not require transcript specific probes, so an unbiased approach.
  • Can detect novel transcripts
  • Broader dynamic range than hybridisation technology. RNAseq quantifies discrete, digital sequencing read counts.
  • RNA seq has increased specificity and sensitivity
  • Easier to detect rare/ low abundance transcripts by increasing sequencing coverage.
34
Q

Disadvantages of RNA seq over microarray technology

A
  • Greater bioinformatic requirements for de novo assembly to detect novel transcripts and gene fusions
  • Higher cost
  • Longer TAT
  • Poorer quantitative accuracy
35
Q

Steps in RNAseq

A

Isolating RNA, converting it to complementary DNA (cDNA), preparing the sequencing library, and sequencing it on an NGS platform, bioinformatic analysis.

36
Q

Examples of the use of RNA based methods

A
  • Assessing intra tumour heterogeneity. Causes of therapy resistance and disease recurrence. Can detect rare subclones.
  • Single cell RNA seq. Good for the analysis of rare cells or heterogeneous populations.